Timmer-Bonte JNH - Search Results

1

Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy.

van den Berg MMGA, Kok DE, Posthuma L, Kamps L, Kelfkens CS, Buist N, Geenen M, Haringhuizen A, Heijns JB, van Lieshout RHMA, Los M, Sommeijer DW, Timmer-Bonte JNH, de Kruif ATCM, van Laarhoven HWM, Kampman E, Winkels RM. van den Berg MMGA, et al. Among authors: timmer bonte jnh. Breast Cancer Res Treat. 2019 Jan;173(2):475-481. doi: 10.1007/s10549-018-5014-5. Epub 2018 Oct 23. Breast Cancer Res Treat. 2019. PMID: 30353244 Free PMC article.

2

Encouraging results in older patients receiving chemotherapy: a retrospective analysis of treatment guideline adherence in daily practice.

Heijmen L, van Laarhoven HW, Punt CJ, van den Hurk D, van der Drift MA, Ottevanger PB, Timmer-Bonte JN. Heijmen L, et al. Geriatr Gerontol Int. 2012 Jan;12(1):80-5. doi: 10.1111/j.1447-0594.2011.00734.x. Epub 2011 Aug 24. Geriatr Gerontol Int. 2012. PMID: 21883785

3

Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041).

van Laarhoven HW, Fiedler W, Desar IM, van Asten JJ, Marréaud S, Lacombe D, Govaerts AS, Bogaerts J, Lasch P, Timmer-Bonte JN, Lambiase A, Bordignon C, Punt CJ, Heerschap A, van Herpen CM. van Laarhoven HW, et al. Clin Cancer Res. 2010 Feb 15;16(4):1315-23. doi: 10.1158/1078-0432.CCR-09-1621. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145168 Free article. Clinical Trial.

4

Timely withdrawal of G-CSF reduces the occurrence of thrombocytopenia during dose-dense chemotherapy.

Timmer-Bonte JN, de Mulder PH, Peer PG, Beex LV, Tjan-Heijnen VC. Timmer-Bonte JN, et al. Breast Cancer Res Treat. 2005 Sep;93(2):117-23. doi: 10.1007/s10549-005-4322-8. Breast Cancer Res Treat. 2005. PMID: 16187231 Clinical Trial.

5

Factors affecting the unexpected failure of DCE-MRI to determine the optimal biological dose of the vascular targeting agent NGR-hTNF in solid cancer patients.

Desar IM, van Herpen CM, van Asten JJ, Fiedler W, Marreaud S, Timmer-Bonte JN, ter Voert EG, Lambiase A, Bordignon C, Heerschap A, van Laarhoven HW. Desar IM, et al. Eur J Radiol. 2011 Dec;80(3):655-61. doi: 10.1016/j.ejrad.2010.08.045. Epub 2010 Sep 21. Eur J Radiol. 2011. PMID: 20863638

6

Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies.

Vriens D, de Geus-Oei LF, van Laarhoven HW, Timmer-Bonte JN, Krabbe PF, Visser EP, Oyen WJ. Vriens D, et al. Nucl Med Commun. 2009 Jul;30(7):550-7. doi: 10.1097/MNM.0b013e32832bdc80. Nucl Med Commun. 2009. PMID: 19424100 Clinical Trial.

7

Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patients.

Timmer-Bonte JNH, Ouwerkerk J, Faber LM, Kerkhofs LGM, Laterveer L, Ten Oever D, van Rees BP, van der Linden PW. Timmer-Bonte JNH, et al. Neth J Med. 2020 Sep;78(5):270-276. Neth J Med. 2020. PMID: 33093252 Free article.

8

Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer.

Soetekouw PM, Timmer-Bonte JN, van der Drift MA, van Leeuwen F, Wagenaar M, van Die L, Bussink J, Tjan-Heijnen VC. Soetekouw PM, et al. Int J Clin Oncol. 2013 Dec;18(6):988-96. doi: 10.1007/s10147-012-0476-7. Epub 2012 Sep 27. Int J Clin Oncol. 2013. PMID: 23011101 Clinical Trial.

9

A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer.

Desar IM, Timmer-Bonte JN, Burger DM, van der Graaf WT, van Herpen CM. Desar IM, et al. Br J Cancer. 2010 Nov 23;103(11):1637-43. doi: 10.1038/sj.bjc.6605777. Epub 2010 Nov 2. Br J Cancer. 2010. PMID: 21045832 Free PMC article. Clinical Trial.

10

Adherence and patients' experiences with the use of oral anticancer agents.

Timmers L, Boons CC, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, Timmer-Bonte JN, Boven E, Hugtenburg JG. Timmers L, et al. Acta Oncol. 2014 Feb;53(2):259-67. doi: 10.3109/0284186X.2013.844353. Epub 2013 Nov 22. Acta Oncol. 2014. PMID: 24266637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page